FUNET builds 400G-ready network on ADVA FSP 3000 open line system
ADVA (FSE: ADV) today announced that CSC – IT Center for Science, which operates the Finnish University and Research Network (FUNET), has deployed ADVA technology in response to soaring bandwidth demand. The new solution is now providing Finland’s universities and research facilities with highly reliable connectivity at speeds up to 200Gbit/s. Built on the ADVA FSP 3000 open line system (OLS), the fully redundant network leverages ADVA’s QuadFlex™ transponders and ultra-flexible ROADM technology. This enables FUNET to rapidly respond to increasing demand for new services and bandwidth at the touch of a button. Continual, real-time assurance is provided by ADVA’s ALM fiber monitoring solution. The network is also ready to expand to 400Gbit/s, ensuring that it will satisfy the needs of Finland’s research and education (R&E) community both now and in years to come.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191121005068/en/
ADVA’s open technology will play a key role in the future of Finland’s research and education community (Photo: Business Wire)
“ADVA’s open, future-proof technology empowers us to support the ambitions of Finland’s researchers, educators and students. They need constant access to high-bandwidth applications and enhanced data sharing. With this network, we can deliver fast, always-on services in a flexible and highly efficient way,” said Matti Laipio, development manager, FUNET network, CSC – IT Center for Science. “Our new solution connects more than 80 organizations with each other, with other Nordic R&E transport networks, and with the world. It also offers researchers rapid access to the high-performance supercomputer in Kajaani. What makes this deployment so valuable, though, is that it provides superb capacity while also enabling an easy route to further expansion. With the inherent scalability of the modular FSP 3000 OLS, we know we’ll be able to continue to meet the demands of learners and scientists.”
By harnessing the ADVA FSP 3000 optical platform for its long-haul network, FUNET is maximizing cost-efficiency and bandwidth utilization. The solution was developed to meet the most stringent density, security and energy demands. And, with its filterless, colorless and directionless ROADMs creating a flexgrid architecture, it gives FUNET the agility to instantly set up and reroute optical links between any nodes. The fiber plant is being monitored 24/7 by the ADVA ALM for highest network availability and service reliability. FUNET is also leveraging ADVA’s Ensemble Controller network management technology for operational simplicity and complete control of the entire infrastructure. What’s more, ADVA’s technology is open, enabling easy connections to other major European R&E networks, including SUNET and NORDUnet.
“Our open technology is ideal for creating a scalable, disaggregated long-haul architecture like FUNET’s new 400Gbit/s-ready network. By working closely together with their team, we’ve been able to design a solution that meets all of their needs and ensure a smooth rollout to every corner of the country,” commented Ari Salomaa, sales director, Finland, ADVA. “This deployment is about empowering academics and scientists across a wide range of fields to go further than ever before. By taking advantage of world-class internet services and cutting-edge, data-intensive tools, Finland’s research community will be free to connect, collaborate and innovate even more.”
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.
About CSC – IT Center for Science
CSC – IT Center for Science is a Finnish center of expertise in information technology owned by the Finnish state and higher education institutions. We provide internationally high-quality ICT expert services for higher education institutions, research institutes, culture, public administration and enterprises to help them thrive and benefit society at large. www.csc.fi
ADVA Optical Networking SE, Munich, Germany
For ADVA press:
t +44 1904 699 358
For ADVA investors:
t +49 89 890 665 854
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EET | Press release
HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme
Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EET | Press release
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants
Lionbridge Names Corinne Saunders as Managing Director, EMEA23.1.2020 21:00:00 EET | Press release
Today, Lionbridge, a global leader in localization and data training services, announced that former Wolters Kluwer executive Corinne Saunders has joined the company as managing director of EMEA. Lionbridge currently has 51 offices in 26 countries around the world; Saunders will oversee EMEA sales, account management, and marketing operations. “Europe represents a large portion of our overall business and will continue to be a growth area for our AI and localization businesses. I am very happy that Corinne is coming onboard to lead our efforts across EMEA,” says Lionbridge Chief Executive Officer John Fennelly. “Throughout her career, she’s shown an exceptional ability for driving innovation and understanding customer needs.” While at Wolters Kluwer, Saunders served as chief executive officer for emerging and developing markets. Saunders will work from Brussels, Belgium. About Lionbridge Lionbridge partners with brands to break barriers and build bridges all over the world. For more th
President Bill Clinton to Keynote 2020 World Patient Safety, Science & Technology Summit23.1.2020 20:34:00 EET | Press release
President Bill Clinton, the 42nd President of the United States, will be the closing keynote speaker at the Patient Safety Movement Foundation’s 2020 World Patient Safety, Science & Technology Summit. The 8th annual Summit will be held in Huntington Beach, California, beginning with a Pre-Summit Symposium on Thursday, March 5th. At the 2020 Summit, hospital leaders, medical and information technology innovators, patient advocates, policy makers and government officials collaborate and discuss best practices solutions to eliminate preventable patient deaths in hospitals around the world. The event is co-convened with the International Society for Quality in Health Care (ISQua), the American Society of Anesthesiologists and the European Society of Anaesthesiology. The 2020 Summit is scheduled for March 5 – 7th, 2020, at the Waterfront Beach Resort in Huntington Beach, California. For more information about the 2020 World Patient Safety, Science & Technology Summit, visit http://patientsa
Covantis initiative announces technology partner - ConsenSys23.1.2020 18:00:00 EET | Press release
The founding members of the Covantis initiative, which aims to modernize global trade operations, have announced the selection of ConsenSys, a market-leading Ethereum blockchain technology company, as the lead technology partner to develop its transformative platform. “The founders set up a robust selection process, including a two week hackathon, to ensure that we chose the right technology partner to meet our industry’s needs,” said Stefano Rettore, independent advisor to the project. “ConsenSys presented prototypes that demonstrated excellence in its field and has a track record of using blockchain technology to digitize processes in the commodity trade finance industry. We are confident this partnership will allow us to build a first-class product, centered around unparalleled functionality, security and privacy.” ConsenSys will leverage its enterprise-ready blockchain solutions and services, including PegaSys Orchestrate, Kaleido and MythX to build the blockchain network on Ethere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom